期刊文献+

Relationship between C-reactive protein and clinical stage in nasopharyngeal carcinoma

鼻咽癌中血清C反应蛋白水平与临床分期的关系(英文)
下载PDF
导出
摘要 Objective: The aim of our study was to explore the correlations between C-reactive protein (CRP) levels and clinical stages of nasopharyngeal carcinoma (NPC). Methods: We analyzed 108 cases, among them, 68 cases were NPC, 20 cases were benign inflammatory diseases of nasopharynx, 20 cases were healthy volunteers as control. CRP was determined with immunoturbidimetry (ITM). Results: The mean concentrations of CRP in NPC (19.76 rag/L) were significantly increased compared to that in the control group (6.23 mg/L), while were significantly lower than that in benign inflammatory group (45.63 mg/L); The mean concentrations of CRP in T4 group (25.58 mg/L) were higher than that in T1 group (17.35 mg/L), T2 group (18.65 mg/L) and T3 group (15.61 mg/L). The mean concentrations of CRP in N3 group (28.04 mg/L) were higher than that in NO (17.62mg/L), N1 (21.27 mg/L), N2 (18.62 mg/L) respectively, the mean concentrations of CRP in IV (25.74 mg/L) were higher than that in I (14.20 mg/L), II (16.10 mg/L), III (23.01 mg/L), respectively. Conclusion: The serum CRP level is associated with the occurrence of NPC and benign inflammatory disease of nasopharynx. In NPC, the CRP level has positive relationship with the TNM stage.
出处 《The Chinese-German Journal of Clinical Oncology》 CAS 2010年第2期89-92,共4页 中德临床肿瘤学杂志(英文版)
关键词 nasopharyngeal carcinoma C-reactive protein clinical stage C反应蛋白 鼻咽癌 临床 平均浓度 蛋白水平 CRP IT管理 免疫测定
  • 相关文献

参考文献9

  • 1Trichopoulos D, Psaltopoulou T, Orfanos P, et al. Plasma C-reactive protein and risk of cancer: a prospective study from Greece. Cancer Epidemiol Biomarkers Prev, 2006, 15: 381-384.
  • 2Ito K, Asano T, Yoshii H, et al. Impact of thrombocytosis and C-reactive protein elevation on the prognosis for patients with renal cell carcinoma. Int J Urol, 2006, 13: 1365-1370.
  • 3Zahlten-Hinguranage A, Goldschmidt H, Cremer FW, et al. Preoperative elevation of serum C--reactive protein is predJctive for prognosis in myeloma bone disease after surgery. Br J Cancer, 2006, 95: 782-787.
  • 4Li J, Zhu YM, Liu YL, The Progress of study on the relationship between inflammation and tumor. Chin J Med Guide (Chinese), 2007, 9:217-219.
  • 5Chiu HM, Lin JT, Chen TH, et al. Elevation of C-reactive protein level Js associated with synchronous and advanced colorectal neoplasm in men. Am J Gastroenterol, 2008, 103: 2317-2325.
  • 6Lawrence T. Inflammation and cancer: a failure of resolution? Trends Pharmacol Sci, 2007, 28: 162-165.
  • 7Polterauer S, Grimm C, Tempfer C, et al. C-reactive protein is a prognostic parameter in patients with cervical cancer. Gynecol Oncol, 2007, 107: 114-117.
  • 8Groblewska M, Mroczko B, Wereszczyrnska-Siemiatkowska U, et al. Serum interleukin 6 (IL-6) and C-reactive protein (CRP)levels in colorectal adenoma and cancer patients. Clin Chem Lab Med, 2008, 46: 1423-1428.
  • 9Shimada H, Nabeya Y, Okazumi S, et al. Elevation of preoperative serum C-reactive protein Jevel is related to poor prognosis Jn esophageal squamous cell carcinoma. J Surg Oncol, 2003, 83: 248-252.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部